DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Neuronal SignalingNeuronal Signaling
  5. /NK ReceptorNK Receptor
  6. /Rolapitant HydrochlorideRolapitant Hydrochloride
Chemical structure of CAS 914462-92-3

Rolapitant Hydrochloride

In Stock•Starting at $79 for 5 mg•Purity ≥ 98%
CAS No.914462-92-3
MDL No.N/A
MFC25H29ClF6N2O3
MW555.00
InChI KeyGZQWMYVDLCUBQX-WVZIYJGPSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$79In Stock
10 mg98%$117In Stock
25 mg98%$201In Stock
50 mg98%$300In Stock
100 mg98%$449In Stock
250 mg98%$805In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Rolapitant hydrochloride hydrate is the monohydrate form of rolapitant hydrochloride. It is used to prevent delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. It functions as an antiemetic and neurokinin-1 receptor antagonist, containing rolapitant hydrochloride (anhydrous).

CAS No.914462-92-3
Product NameRolapitant Hydrochloride

Biological Targets

TACR1

Associated Conditions

Chemotherapy-induced nausea and vomiting·Nausea·sarcoma·Vomiting
* The information provided here is compiled from public sources and is for reference only.

Documentation

Similar Products

  • Rolapitant

    CAS No.552292-08-7

  • Rolapitant metabolite M19

    CAS No.2238886-63-8

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact